| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/23/2008 | CN100404512C Crystalline form beta-d of the chlorohydrate of ivabradine, process for its preparation and pharmaceutical compositions containing it |
| 07/23/2008 | CN100404509C Isoquinoline compound, preparation method and application of salt thereof |
| 07/23/2008 | CN100404055C Externally applied pile treating medicine and its producing method and usage |
| 07/23/2008 | CN100404051C Chinese medicinal composition for treating coronary heart disease, stenocardia and its preparation method |
| 07/23/2008 | CN100404042C Process for preparing soft capsule of red sage root and notoginseng |
| 07/23/2008 | CN100404041C Medicinal composition for treating coronary heart disease |
| 07/23/2008 | CN100404040C Medicinal composition for treating cardiopathy and its preparation method and use |
| 07/23/2008 | CN100404039C Safflower medicine composition and its preparation process and use |
| 07/23/2008 | CN100404036C Ointment for treating piles |
| 07/23/2008 | CN100404035C Composition of Chinese traditional medicine for curing cardiovascular diseases and cerebrovascular disease |
| 07/23/2008 | CN100404028C Novel use of Brazil Hematine red |
| 07/23/2008 | CN100404024C Synergestic combinations comprising renin inhibitor for cardiovascular diseases |
| 07/23/2008 | CN100404020C Chuanxiong rhizome volatile oil soft capsule and its preparation method |
| 07/23/2008 | CN100403939C Antihypertensive functional beverage and its preparation process |
| 07/22/2008 | US7403805 Apparatus and method for noninvasive measurement of analytes from the conjunctiva using mid-infrared radiation |
| 07/22/2008 | US7402696 exert an ACC activity-inhibiting effect that is effective in the treatment of obesity, hyperlipemia, fatty liver, hyperglycemia, impaired glucose tolerance, diabetes, diabetic complications (diabetic peripheral neuropathy, diabetic nephropathy, diabetic retinopathy, and diabetic macroangiopathy, hyperten |
| 07/22/2008 | US7402682 affinity for peripheral-type benzodiazepine receptors; in vitro and in vivo affinity; chemical intermediates |
| 07/22/2008 | US7402660 Inhibiting neoangiogenesis by administering a molecule with an antibody variable region which specifically binds to an extracellular domain of a TEM protein |
| 07/22/2008 | US7402605 E.g., 17,17-propano-16-hydroxy-5-(4-ethoxycarbonylthiazol-2-yl)-9-oxo-1,2,3,4,20-pentanor-5-thia-8-azaprost-13-ene; EP2 and/or EP4 receptor agonist; immune disease; antiallergens; alopecia; dysmenorrhea; erectile dysfuncction; antiarthritic agents; liver, respiratory, vascular, urogenital disorder |
| 07/22/2008 | US7402602 Imidazole derivatives modulating the sodium channels |
| 07/22/2008 | US7402600 Nitroderivatives of cardiovascular agents |
| 07/22/2008 | US7402597 e.g. [[7-Allyl-3-[2-[2-(2,4-dichlorophenyl)-5-isopropyl-4-oxazolyl]ethyl]-1,2-benzisoxazol-6-yl]oxy]acetic acid; with vehicles (lactose, D-mannitol, glucose), disintegrators (starch or carboxymethylcellulose calcium ), binders (hydroxypropylcellulose) and lubricants (magnesium stearate or talc) |
| 07/22/2008 | US7402595 JNK inhibitor |
| 07/22/2008 | US7402590 Spiroazacyclic compounds as monoamine receptor modulators |
| 07/22/2008 | US7402586 3-Benzylsulfonylamino-6-methyl-1-[(3-guanidinooxypropyl)aminocarbonylmethyl]-2-pyridinone trifluoroacetate; anticoagulants either embedded in or physically linked to materials used in the manufacture of devices used in blood collection, blood circulation, and blood storage |
| 07/22/2008 | US7402581 3,5-Dibromo-N-[(2S)-2-(4-fluorophenyl)-4-(3-morpholin-4-ylazetidin-1-yl)butyl]-N-methylbenzamide; neurokinin 1 and 2 (NK1,2) receptors, antagonist; improved pharmacokinetics: not inhibit liver enzyme cytochrome P450, prevent drug-drug interactions, oral bioavailability, antiinflammatory and analgesic |
| 07/22/2008 | US7402580 Polymerase inhibitors; antiischemic agents; brain disorders; cardiovascular disorders; antiinflammatory agents; antiarthritic agents; neurodegenerative agents; Alzheimer's disease; muscular disorders; antidiabetic agents; kidney disorders; viricides; anticancer agents; immunosuppressants |
| 07/22/2008 | US7402577 Androstane 17-beta-carboxamides as androgen receptor modulators |
| 07/22/2008 | US7402560 oligopeptides capable of stimulating the proliferation or/and the outgrowth from cells presenting the neural cell adhesion molecule (NCAM), used for treatment of normal, degenerated and damaged NCAM presenting cells |
| 07/22/2008 | US7402395 Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 07/22/2008 | US7402393 Methods of screening for antagonists of APM1/GZIP |
| 07/22/2008 | US7402305 Comprises nucleotide sequences coding protein with antiproliferative and viricidal activity for use in treatment and prevention of cancer, nervous system, bone and autoimmune disorders |
| 07/22/2008 | US7402299 Intracorporeal medicaments for photodynamic treatment of disease |
| 07/22/2008 | CA2481246C Compounds that modulate ppar activity and methods for their preparation |
| 07/22/2008 | CA2383011C Therapeutic uses of polymers and oligomers comprising gamma-hydroxybutyrate |
| 07/22/2008 | CA2372840C Substituted bicyclic compounds |
| 07/22/2008 | CA2310748C Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation |
| 07/22/2008 | CA2278223C 1,4-dihydropyridin derivatives and their use in therapy |
| 07/22/2008 | CA2265095C Pyrazolopyrimidines and pyrazolotriazines |
| 07/17/2008 | WO2008086188A2 Thiophene carboxamides as factor xa inhibitors |
| 07/17/2008 | WO2008086047A1 Rho kinase inhibitors |
| 07/17/2008 | WO2008085492A2 Methods and compositions for modulating bk channel activity and vasodilation |
| 07/17/2008 | WO2008085074A2 1, 3-dihydroimidazoles for treating cardiovascular disorders |
| 07/17/2008 | WO2008085019A1 A method for lowering risk of cardiovascular diseases |
| 07/17/2008 | WO2008084873A1 Oxime derivative |
| 07/17/2008 | WO2008084864A1 Capsaicin receptor activator and apparatus for spraying the same |
| 07/17/2008 | WO2008084828A1 Method for producing coenzyme q10 particle |
| 07/17/2008 | WO2008084574A1 Anti-angiogenic agent |
| 07/17/2008 | WO2008084504A2 Pharmaceutical compositions of angiotensin ii receptor blockers |
| 07/17/2008 | WO2008084494A1 Novel polymorphic forms of carvedilol dihydrogen phosphate and process for preparing the same |
| 07/17/2008 | WO2008084268A1 Use of biglycan or enhancers of biglycan activity in the preparation of pharmaceutical compositions |
| 07/17/2008 | WO2008084005A1 Spiropiperidine glycinamide derivatives |
| 07/17/2008 | WO2008061248A3 Phenylsulfoxyoxazole compound inhibitors of urea transporters |
| 07/17/2008 | WO2008002683A3 Polymorphous forms of carvedilol phosphate |
| 07/17/2008 | WO2007139972A8 Expression of the cysteine protease legumain in vascular and inflammatory diseases |
| 07/17/2008 | US20080171882 [(4S)-4-Methyl-2,5-dioxoimidazolidin-4-yl]methanesulfonyl chloride and [(4R)-4-methyl-2,5-dioxoimidazolidin-4-yl]methanesulfonyl chloride; chemical intermediates for enzyme inhibitors |
| 07/17/2008 | US20080171853 Formed via solid-state chemistry with 4-methylbenzylhydrylamine functionalized crosslinked polystyrene resin; deblocking, deprotecting; methylation |
| 07/17/2008 | US20080171789 Catechol protected levodopa diester prodrugs, compositions, and methods of use |
| 07/17/2008 | US20080171786 Substituted [(Phenylethanoyl)Amino]Benzamides |
| 07/17/2008 | US20080171782 2-[5-(3-Methylphenyl)-1-octyl-1H-indol-3-yl]acetamide (cysmethynil) and derivatives; anticarcinogenic agents; leukemia; antiinflammatory agents; multiple sclerosis, antiarthritic agents; rheumatic diseases;osteoporosis, stroke, asthma; glaucoma; screening; catalyzed CaaX protein methylation |
| 07/17/2008 | US20080171778 N3 alkylated benzimidazole derivatives as mek inhibitors |
| 07/17/2008 | US20080171775 Ramipril-amlodipine salt |
| 07/17/2008 | US20080171772 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (s1p) receptor antagonist biological activity |
| 07/17/2008 | US20080171769 Tricyclic compound derivatives useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders |
| 07/17/2008 | US20080171764 Determining the efficiency of treating atherosclerosis by inhibiting the infiltration and/or accumulation of inflammatory cells proximate a site of altered vascular tissue by using an agent binding FK binding protein and inhibiting mTOR (mammalian target of rapamycin); sirolimus and analogs |
| 07/17/2008 | US20080171746 Method for Preventing Cardiovascular Diseases |
| 07/17/2008 | US20080171739 e.g. 1-(3-(6-(2-fluorophenyl)pyridin-3-yl)propyl)-1H-pyridin-2-one; endothelial nitric oxide NO synthase inhibitor; antiinflammatory, hypotensive agent; atherosclerosis, thrombosis, coronary artery disease, and cardiac insufficiency |
| 07/17/2008 | US20080171730 Administration of estradiol metabolites for the treatment or prevention of obesity, metabolic syndrome, diabetes and vascular and renal disorders |
| 07/17/2008 | US20080171702 Novel gene and uses therefor |
| 07/17/2008 | US20080171697 Mitochondriotoxic cyclic polypeptides that induce endocytolysis or angiogenesis in human endothelial cells expressing alpha V beta 3 receptors; anticarcinogenic agents for adenomas, melanomas, osteosarcomas, prostate, breast, colon, or pancreatic cancers; antiarthritici agents; diabetic retinopathy |
| 07/17/2008 | US20080171692 Substituted amides |
| 07/17/2008 | US20080171086 Solid Dosage Forms of Valsartan and Amlo Dipine and Method of Making the Same |
| 07/17/2008 | US20080171060 Lymphocyte receptor peptide for use in prevention and treatment of viral infection, cell proliferative, cardiovascular and allergic disorders; enhancing cytokine production |
| 07/17/2008 | US20080171052 Hmgb1 protein inhibitorsand/or antagonists for the treatment of vascular diseases |
| 07/17/2008 | US20080171021 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation |
| 07/17/2008 | US20080171017 Therapeutic mixture comprising chimeric interleukin receptor, microbiocidal, antiproliferative and chemotherapeutic agent for use in treatment and prevention of infectious and cancer disorders |
| 07/17/2008 | DE60130743T2 Mikrokugeln zur aktiven embolisierung Microspheres for embolization active |
| 07/17/2008 | DE202008005023U1 Verwendung von α-Liponsäure und Coenzym Q10 zur selektiven Reduktion des visceralen Fettgewebes Use of α-lipoic acid and coenzyme Q10 for the selective reduction of visceral adipose tissue |
| 07/17/2008 | DE102007002386A1 Pharmazeutisch wirksame Verbindungen Pharmaceutically active compounds |
| 07/17/2008 | CA2674958A1 Spiropiperidine glycinamide derivatives |
| 07/17/2008 | CA2674843A1 Factor xa inhibitors |
| 07/17/2008 | CA2674389A1 Rho kinase inhibitors |
| 07/17/2008 | CA2674305A1 Therapy |
| 07/17/2008 | CA2618691A1 Methods for preventing, managing, and reversing disease caused by inflammation mediated vascular lesions |
| 07/16/2008 | EP1944317A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/16/2008 | EP1944301A1 Novel benzoxathiin derivative |
| 07/16/2008 | EP1944292A1 8-substituted-2,6-methano-3-benzazocines and 3-substituted morphinanes as opioid receptor binding agents |
| 07/16/2008 | EP1944290A1 Novel 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity |
| 07/16/2008 | EP1944034A1 Adsorbent for advanced glycation endproducts |
| 07/16/2008 | EP1944031A1 use of ivabradine for the treatment of endothelial dysfunction |
| 07/16/2008 | EP1944026A2 Use of EDG receptor binding agents in cancer |
| 07/16/2008 | EP1944024A1 O-substituted aniline derivative and antioxidant drug |
| 07/16/2008 | EP1943251A2 A1 adenosine receptor agonists |
| 07/16/2008 | EP1942985A1 Methods for reducing blood pressure |
| 07/16/2008 | EP1942942A2 Polysaccharide-derived nitric oxide-releasing carbon-bound diazeniumdiolates |
| 07/16/2008 | EP1942930A2 Enzyme inhibitors of pai-1 |
| 07/16/2008 | EP1942921A2 Combination of a dipeptidyl peptidase-4 inhibitor and an anti-hypertensive agent for the treatment of diabetes and hypertension |
| 07/16/2008 | EP1942919A2 Method for lowering blood pressure in pre-hypertensive individuals and/or individuals with metabolic syndrome |
| 07/16/2008 | EP1942904A2 Cholesteryl ester transfer protein inhibitors |
| 07/16/2008 | EP1942900A2 Use of pyrazolo [1,5-a] pyrimidine derivatives for inhibiting kinases methods for inhibiting protein kinases |